Cost-Effectiveness of Ferrous Fumarate-Folic Acid and Ferrous Gluconate-Multivitamins in a High Prevalence Area of Iron Deficiency Anemia in Indonesia.
Yasinta RakanitaMas Rizky A A SyamsunarnoRano Kurnia SinurayaEka W SuradjiRizky AbdulahAuliya Abdurrohim SuwantikaPublished in: Therapeutics and clinical risk management (2021)
The ICER was estimated to be $11.59 per QALY gained, which was highly cost-effective, according to GDP-based cost-effectiveness threshold. In addition, the utility score of women with iron deficiency anemia was considered to be the most influential factor impacting the cost-effectiveness value.
Keyphrases